Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma 15Lymphoma, Mantle-Cell 14Lymphoma, Large B-Cell, Diffuse 14Leukemia, Lymphocytic, Chronic, B-Cell 12Hodgkin Disease 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Waldenstrom Macroglobulinemia 10Lymphoma, Follicular 10Lymphoma, Non-Hodgkin 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, Large-Cell, Anaplastic 7Immunoblastic Lymphadenopathy 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, T-Cell, Cutaneous 6Burkitt Lymphoma 6Sezary Syndrome 5Recurrence 5Mycosis Fungoides 5Multiple Myeloma 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma, B-Cell 4Leukemia 4Neoplasms, Plasma Cell 3Lymphoproliferative Disorders 3Lymphoma, Large-Cell, Immunoblastic 3Primary Myelofibrosis 2Lymphoma, T-Cell 2Lymphatic Diseases 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2

Interventions

Rituximab 9Cyclophosphamide 8fludarabine 5dacetuzumab 5blinatumomab 5Brentuximab Vedotin 4Bendamustine Hydrochloride 4ibrutinib 3fludarabine phosphate 3Vincristine 3Prednisone 3Melphalan 3Etoposide 3Doxorubicin 3tetulomab tetraxetan lu-177 2ponatinib 2cobomarsen 2acalabrutinib 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Lutetium 2Ifosfamide 2Everolimus 2Carboplatin 2Busulfan 2Bone Marrow Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphatic Diseases × Everolimus × Lymphoid × Clear all
NCT04305444 2025-01-08

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Zhejiang DTRM Biopharma

Phase 2 Terminated
55 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01022996 2016-05-18

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Novartis

Phase 2 Completed
57 enrolled 10 charts
Lymphoid

Hemic and Lymphatic Diseases, Hodgkin Disease, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡